SEC Form 4 · accession 0001723128-19-000013
Amneal Pharmaceuticals, Inc. · AMRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert L Burr
Director
Period of report
Jan 15, 2019
Accepted (ET)
Jan 16, 2019 · 5:16 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001723128
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Jan 15, 2019 | M | 30,000 | $6.55 | A | 90,475 | D | |
| Class A Common Stock | holding | — | — | — | 6,057 | I | By the Robert L. Burr IRA Account |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1 | $6.55 | Jan 15, 2019 | M | 30,000 | D | — | May 20, 2019 | Class A Common Stock | 30,000 | 0 | D |
Explanation of responses
- F1The option is vested and currently exercisable.